XM does not provide services to residents of the United States of America.

Data analytics firm Palantir jumps as AI boom powers robust software adoption



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Data analytics firm Palantir jumps as AI boom powers robust software adoption</title></head><body>

Nov 5 (Reuters) -Palantir shares PLTR.N jumped over 12% on Tuesday after the data analytics firm raised its annual revenue forecast for the third time, bolstering investor confidence that the artificial intelligence boom was fueling demand for its services.

The company is among the biggest stock market winners of the generative AI boom, with its shares more than doubling in value this year — a rally that has sparked concerns over its steep valuation.

But Palantir's results late on Monday allayed some of those fears as demand rose thanks to its AI platform, which is used to test, debug code and evaluate AI-related scenarios, as well as its government-oriented services that include software to visualize army positions.

Palantir raised its revenue forecast to between $2.805 billion and $2.809 billion for 2024, from its previous projected range of $2.742 billion to $2.750 billion.

For the third quarter, the company saw its revenue from U.S. government contracts surge 40%, which made up more than 44% of its total sales of $725.5 million.

"We see a long runway of growth in the government sector, owing to the massive demand for AI-first solutions across governmental functions such as the military and healthcare," Morningstar analysts said.

But the analysts cautioned that the stock's recent surge in value means that "any bump in the road, such as sales execution challenges or weaker-than-expected top-line growth or guidance, could materially affect the stock's valuation".

If premarket gains hold through the day, Palantir is expected to add $12 billion to its market value.

It trades at a forward price-to-earnings ratio of 95.43, compared with 25.60 for peers Oracle ORCL.N and 126.92 for Snowflake SNOW.N.

Palantir stock has outperformed the S&P 500 .SPX index this year. It was added to the benchmark index late-September.



Reporting by Zaheer Kachwala in Bengaluru; Editing by Shilpi Majumdar

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.